Digestive neuroendocrine tumors (NETs) form a heterogeneous group of rare tumors whose characteristics vary according to site and associated hormonal syndrome. Prognosis depends essentially on histology, which makes precise classification according to tumor grade (WHO) essential. The aim of our work was to study the epidemio-clinical profile, prognostic factors and therapeutic modalities of NETs.
